RA
BSTG

Royce & Associates’s Biostage, Inc. Common Stock BSTG Stock Holding History

Royce & Associates’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-73,405
Closed -$233K – 1329
2014
Q4 		$233K Sell
73,405
-98,669
-57% -$489K ﹤0.01% 1182
2014
Q3 		$1.39M Hold
172,074
– – ﹤0.01% 1071
2014
Q2 		$1.8M Sell
172,074
-19,700
-10% -$168K 0.01% 1057
2014
Q1 		$1.74M Hold
191,774
– – 0.01% 1075
2013
Q4 		$911K Buy
+191,774
New +$897K ﹤0.01% 1182

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Royce & Associates's BSTG Position: Q1 2015 in Review

Royce & Associates sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2015, closing a stake of 73,405 shares — an estimated $233K sold.

Royce & Associates first reported a position in BSTG in Q4 2013 and held it in 5 quarters. The position peaked at $1.8M in Q2 2014. 37 funds tracked by Wall St. Rank hold BSTG as of Q1 2015.

  • Royce & Associates reported no remaining Biostage, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Royce & Associates sold 73,405 Biostage, Inc. Common Stock shares in Q1 2015, an estimated $233K.
  • Royce & Associates first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • Royce & Associates's Biostage, Inc. Common Stock position peaked at $1.8M in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.